Fundz

Bio Line Rx Ltd. reported raising $4.39 Million in an initial SEC Form D filing, from an offering of $4.39 Million

PUBLIC · BLRXJun 10, 2020

Amount Raised

$4.39 Million

$4.39 Million sold, per SEC Form D (first sale Jun 10, 2020)

Round Type

Pre-Seed

Tel AvivBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaresearch

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as BioLineRx Ltd that raised within 45 days of this round, from Fundz verified event records.

Who to call at BioLineRx Ltd, and when

A new round usually means BioLineRx Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioLineRx Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioLineRx Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioLineRx Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioLineRx Ltd

Location

2 HaMa'ayan Street

Tel Aviv, Tel Aviv District, Israel

About

BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company's first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., the company is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioLineRx Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPhil, Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioLineRx Ltd's next move

See what Strategic adds

BioLineRx Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.